KSR2 and coronary artery disorder: In addition, western blot and RT-qPCR analyses demonstrated significantly reduced KSR2 protein and mRNA levels in coronary artery tissues from clinically diagnosed CAD patients compared to non-CAD controls (Figure 2D-E), with baseline characteristics of the patient cohorts summarized in Table S1.